| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combined “eat me/don’t eat me” strategy based on exosome for acute liver injury treatment
|
Du, Wei
|
|
|
6 |
4 |
p.
|
artikel
|
| 2 |
A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer
|
Balaguer-Montero, Maria
|
|
|
6 |
4 |
p.
|
artikel
|
| 3 |
ACVR2A attenuation impacts lactate production and hyperglycolytic conditions attracting regulatory T cells in hepatocellular carcinoma
|
Yasukawa, Koya
|
|
|
6 |
4 |
p.
|
artikel
|
| 4 |
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients
|
Hu, Mengyun
|
|
|
6 |
4 |
p.
|
artikel
|
| 5 |
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
|
Fiore, Danilo
|
|
|
6 |
4 |
p.
|
artikel
|
| 6 |
A peek into the pipeline: Expert views on emerging therapies
|
Dewachter, Ilse
|
|
|
6 |
4 |
p.
|
artikel
|
| 7 |
Arun Sharma
|
Sharma, Arun
|
|
|
6 |
4 |
p.
|
artikel
|
| 8 |
A spatially resolved transcriptome landscape during thyroid cancer progression
|
Liao, Tian
|
|
|
6 |
4 |
p.
|
artikel
|
| 9 |
Balancing ethical data sharing and open science for reproducible research in biomedical data science
|
Lvovs, Dmitrijs
|
|
|
6 |
4 |
p.
|
artikel
|
| 10 |
CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer
|
Chia, Shumei
|
|
|
6 |
4 |
p.
|
artikel
|
| 11 |
Catalytic neural stem cell exosomes for multi-stage targeting and synergistical therapy of retinal ischemia-reperfusion injury
|
Yang, Weiqiang
|
|
|
6 |
4 |
p.
|
artikel
|
| 12 |
Celebrating 5 years of Cell Reports Medicine with authors: Past and future
|
Yu, Jun
|
|
|
6 |
4 |
p.
|
artikel
|
| 13 |
Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages
|
Wang, Zhibo
|
|
|
6 |
4 |
p.
|
artikel
|
| 14 |
Challenges and opportunities in microRNA-based cancer therapeutics
|
Ju, Jingfang
|
|
|
6 |
4 |
p.
|
artikel
|
| 15 |
Common and specific effects in brain oscillations and motor symptoms of tDCS and tACS in Parkinson’s disease
|
Liu, Jiafang
|
|
|
6 |
4 |
p.
|
artikel
|
| 16 |
Deciphering immune predictors of immunotherapy response: A multiomics approach at the pan-cancer level
|
Li, Xuexin
|
|
|
6 |
4 |
p.
|
artikel
|
| 17 |
Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific
|
Sacco, Joseph J.
|
|
|
6 |
4 |
p.
|
artikel
|
| 18 |
Five Years of Cell Reports Medicine
|
|
|
|
6 |
4 |
p.
|
artikel
|
| 19 |
Gut microbiota and metabolites are linked to disease progression in multiple sclerosis
|
Schwerdtfeger, Luke A.
|
|
|
6 |
4 |
p.
|
artikel
|
| 20 |
Herpes simplex virus 1 encodes a STING antagonist that can be therapeutically targeted
|
Wang, An
|
|
|
6 |
4 |
p.
|
artikel
|
| 21 |
Importance of cohort and target trial emulation in clinical research
|
Liang, Xiaohua
|
|
|
6 |
4 |
p.
|
artikel
|
| 22 |
Inhibition of basal IL-6 activity promotes subcutaneous fat retention in humans during fasting and postprandial states
|
Trinh, Beckey
|
|
|
6 |
4 |
p.
|
artikel
|
| 23 |
KLRG1 re-defines a leukemic clone of CD8 effector T cells sensitive to PI3K inhibitor in T cell large granular lymphocytic leukemia
|
Zhang, Lele
|
|
|
6 |
4 |
p.
|
artikel
|
| 24 |
MetaGP: A generative foundation model integrating electronic health records and multimodal imaging for addressing unmet clinical needs
|
Liu, Fei
|
|
|
6 |
4 |
p.
|
artikel
|
| 25 |
Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunity
|
Antonini Cencicchio, Martina
|
|
|
6 |
4 |
p.
|
artikel
|
| 26 |
Microneedle delivery of CAR-M-like engineered macrophages alleviates intervertebral disc degeneration through enhanced efferocytosis capacity
|
Zhou, Xingyu
|
|
|
6 |
4 |
p.
|
artikel
|
| 27 |
Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
|
Tursi, Nicholas J.
|
|
|
6 |
4 |
p.
|
artikel
|
| 28 |
Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies
|
Lopez, Juanita S.
|
|
|
6 |
4 |
p.
|
artikel
|
| 29 |
Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting response
|
Alcindor, Thierry
|
|
|
6 |
4 |
p.
|
artikel
|
| 30 |
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology
|
Wang, Yu-Qing
|
|
|
6 |
4 |
p.
|
artikel
|
| 31 |
Priyanka Baloni
|
Baloni, Priyanka
|
|
|
6 |
4 |
p.
|
artikel
|
| 32 |
Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translation
|
Aguirre, Nicole
|
|
|
6 |
4 |
p.
|
artikel
|
| 33 |
Screening of patient-derived organoids identifies mitophagy as a cell-intrinsic vulnerability in colorectal cancer during statin treatment
|
Tao, Zhi-Hang
|
|
|
6 |
4 |
p.
|
artikel
|
| 34 |
Single-cut gene therapy in a one-step generated rhesus monkey model of Duchenne muscular dystrophy
|
Bai, Raoxian
|
|
|
6 |
4 |
p.
|
artikel
|
| 35 |
Specific macrophage RhoA targeting CRISPR-Cas9 for mitigating osteoclastogenesis-induced joint damage in inflammatory arthritis
|
Chen, Jianhai
|
|
|
6 |
4 |
p.
|
artikel
|
| 36 |
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
|
Plummer, Ruth
|
|
|
6 |
4 |
p.
|
artikel
|
| 37 |
Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis
|
Kim, Dong-Hyun
|
|
|
6 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving